As of June 18, 2025, Ameritek Ventures's estimated intrinsic value ranges from $0.00 to $0.19 per share, depending on the valuation methodology applied.
| Valuation Method | Fair Value (USD) | Implied Upside/Downside |
|---|---|---|
| Discounted Cash Flow (10Y) | $0.19 | +6833.6% |
| Discounted Cash Flow (5Y) | $0.17 | +6185.6% |
| Dividend Discount Model (Multi-Stage) | $0.08 | +2884.7% |
| Dividend Discount Model (Stable) | $0.12 | +4444.9% |
| Earnings Power Value | $0.00 | +2.0% |
Is Ameritek Ventures (ATVK) undervalued or overvalued?
With the current market price at $0.00, the stock appears to be significantly undervalued.
Intrinsic value represents the "true" worth of a company based on its fundamentals rather than market sentiment. We've employed multiple methodologies to triangulate Ameritek Ventures's intrinsic value, including:
The cost of capital is a critical factor in valuation models, representing the required return for investors.
| WACC Component | Low | High |
|---|---|---|
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.52 | 0.77 |
| Cost of equity | 6.3% | 9.2% |
| Cost of debt | 4.5% | 4.5% |
| Tax rate | 26.2% | 27.0% |
| Debt/Equity ratio | 1.22 | 1.22 |
| After-tax WACC | 4.6% | 5.9% |
Our DCF model projects cash flows over 5-year and 10-year horizons, with the following key assumptions:
| DCF Model | Fair Value | Enterprise Value | % from Terminal Value |
|---|---|---|---|
| 5-Year Growth | $0 | $78M | 79.6% |
| 10-Year Growth | $0 | $86M | 64.5% |
| 5-Year EBITDA | $0 | $20M | 21.7% |
| 10-Year EBITDA | $0 | $35M | 11.4% |
The DDM values a company based on its expected future dividend payments. We used two approaches:
EPV assesses a company's value based on its current normalized earnings power, assuming no growth.
| EPV Component | Value |
|---|---|
| Normalized Earnings | $0M |
| Discount Rate (WACC) | 5.9% - 4.6% |
| Enterprise Value | $2M - $3M |
| Net Debt | $1M |
| Equity Value | $1M - $2M |
| Outstanding Shares | 446M |
| Fair Value | $0 - $0 |
| Selected Fair Value | $0.00 |
| Metric | Value |
|---|---|
| Market Capitalization | $1M |
| Enterprise Value | $3M |
| Trailing P/E | 0.27 |
| Forward P/E | 0.36 |
| Trailing EV/EBITDA | 1.10 |
| Current Dividend Yield | 0.00% |
| Dividend Growth Rate (5Y) | 0.00% |
| Debt-to-Equity Ratio | 1.22 |
To determine the most reliable intrinsic value estimate, we weigh each valuation method based on:
| Valuation Method | Weight | Weighted Value |
|---|---|---|
| Discounted Cash Flow (10Y) | 30% | $0.06 |
| Discounted Cash Flow (5Y) | 25% | $0.04 |
| Dividend Discount Model (Multi-Stage) | 20% | $0.02 |
| Dividend Discount Model (Stable) | 15% | $0.02 |
| Earnings Power Value | 10% | $0.00 |
| Weighted Average | 100% | $0.14 |
Based on our comprehensive valuation analysis, Ameritek Ventures's weighted average intrinsic value is $0.14, which is approximately 4840.3% above the current market price of $0.00.
Key investment considerations:
Given these factors, we believe Ameritek Ventures is currently significantly undervalued with the potential for long-term appreciation based on the company's growth trajectory and financial strength.